- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04967313
Behavior Change Techniques (BCTs) to Improve Low Intensity Physical Activity in Older Adults
June 9, 2022 updated by: Karina Davidson, Northwell Health
A Randomized, Controlled Trial to Test Behavior Change Techniques (BCTs) to Improve Low Intensity Physical Activity in Older Adults
The purpose of this pilot study is to determine the feasibility of using personalized trial methods in a virtual research study with Northwell employees aged 45-75 years old to increase low-intensity walking by 2,000 steps per day/5 days per week using four behavior change techniques (BCTs), provided in random order, and shown to have been effective in changing physical activity.
The study will include a two-week baseline period during which levels of physical activity and adherence to the trial protocol will be evaluated.
Individuals meeting adherence criteria will be randomized to the eight-week BCT intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this pilot study is to determine the feasibility of using personalized trial methods in a virtual research study with Northwell employees aged 45-75 years old to increase low-intensity walking by 2,000 steps per day/five days per week using four behavior change techniques (BCTs), provided in random order, and shown to have been effective in changing physical activity.
This pilot will help determine if a personalized, virtual trial design can have widespread use in future research and clinical practice.
The investigators will randomize 60 participants.
Participants will complete a two-week baseline period during which they will be asked to wear a Fitbit device all day and night, even while they are sleeping, and to acknowledge receipt of a daily text message that is not an activity prompt.
Baseline participants will be instructed to sync their Fitbit device by opening the Fitbit app on their phone at least every two days.
After completion of the baseline period, a clinical research coordinator will review individual adherence to Fitbit wear and to survey responses.
Adherence to Fitbit wear will be defined as recorded activity of greater than 10 hours a day.
Text message adherence will be defined as responding to a given text message.
Baseline participants that do not achieve at least 80% adherence of Fitbit wear and text responsiveness during the two weeks of the baseline period will be withdrawn from the study.
Those that maintain at least 80% adherence will be randomized to one of their selected behavior change techniques to begin their pilot personalized trial.
Participants who are randomized to receive intervention sequences will receive email confirmation including their protocol timeline.
Enrollment will continue until up to 60 participants have been randomized.
Individuals in the intervention period will receive four BCTs: goal setting, action planning, self-monitoring of behavior, and feedback on behavior.
BCTs will be delivered individually to participants over the course of eight weeks in four two-week blocks.
The order of BCT administration will be randomized by the study statistician.
Participants may receive additional text messages to those outlined above with important reminders to sync their data as needed.
Upon completion, participants in the personalized trials phase will receive an individual report that demonstrates their walking responses in relation to their selected BCTs.
After receiving the report, clinical research coordinators will contact participants to respond to questions and to obtain feedback about their personalized trials experience.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10022
- Center for Personalized Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 45 - 75 years old of age
- Fluent in English
- Employed in the Northwell Health system
- Community-dwelling
- Report they are in good general health, walk regularly and have never been informed by a clinician that it was not advisable/safe to participate in a low-intensity walking program
- Owns and can regularly access a smartphone capable of receiving text messages
- Owns and can regularly access an e-mail account
Exclusion Criteria:
- < 45 years old or > 75 years old
- Unable to speak/comprehend English
- Not employed in Northwell Health system
- Have self-reported poor health, limited mobility and/or have been advised by a clinician not to increase their low-intensity walking
- Pregnancy
- Previous diagnosis of a serious mental health condition or psychiatric disorder, such as bipolar disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Behavioral Change Techniques to Increase Walking
Individuals will receive daily text messages with the goal of increasing daily walking by 2,000 more steps five days per week.
Participants will be enrolled for a baseline period lasting two weeks where their average daily activity level will be assessed using a Fitbit device to generate an average daily step counts.
Following completion of baseline, participants will receive daily text messages of behavior change techniques (BCTs) for eight weeks.
The four BCTs utilized in this study are: goal setting, action planning, self-monitoring of behavior, and feedback on behavior.
Each BCT will be delivered to participants daily for a two-week block.
Four blocks (one BCT per block) will be delivered to the participant.
The order in which the BCT interventions are presented to participants will be randomized by the study statistician.
The goal of the BCT text messages will be to encourage walking behavior.
|
Four behavioral changes techniques (BCTs) will be administered to participants in random order. The BCTs are defined as follows:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Within-person change in Daily Steps.
Time Frame: Steps will be assessed continuously via worn activity tracker. Step counts will be aggregated and analyzed at the daily level. This will yield 70 daily measurements of physical activity over the course of the 10-week study.
|
Participant steps will be assessed continuously using a Fitbit mobile device.
Daily steps for participants will be aggregated by baseline and intervention phases to generate average daily steps in each phase.
Changes in daily steps between baseline and intervention phases will be compared using Generalized Linear Mixed Model analyses.
|
Steps will be assessed continuously via worn activity tracker. Step counts will be aggregated and analyzed at the daily level. This will yield 70 daily measurements of physical activity over the course of the 10-week study.
|
|
Participant Satisfaction with Personalized Trial Components.
Time Frame: Assessed once after completion of the study at 10 weeks.
|
Participants will rate their satisfaction with the Personalized Trial overall and with individual elements of the trial in a satisfaction survey developed for this trial.
Participants will rate 9 items assessing satisfaction with methods and process of the trial on a 4-point Likert scale with responses ranging from "Not at all satisfied" to "Very satisfied".
Means and standard deviations will be reported for each element of satisfaction.
|
Assessed once after completion of the study at 10 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-Efficacy for Walking
Time Frame: Assessed at baseline, week 2, week 4, week 6, week 8, and week 10.
|
This will be assessed using the Self-Efficacy for Walking (SE-W) scale,[1] an 10-item measure assessing patient's capabilities to walk for durations of 5 to 50 minutes.
Items are scored from 0 to 100%, with scores of 0% indicating participants are "not at all confident" they could walk for that duration and scores of 100% indicating the participants are "highly confident" they could walk that duration.
Items are average to create a total score, with higher scores indicating higher levels of beliefs about capabilities/self-efficacy.
|
Assessed at baseline, week 2, week 4, week 6, week 8, and week 10.
|
|
Participant Attitudes and Opinions towards Personalized Trials.
Time Frame: Assessed once after completion of the study at 10 weeks.
|
Participants will be asked via survey about their attitudes and opinions regarding the personalized trial implementation (e.g., Did the trial feel burdensome?).
Participants will rate items on a 7-point Likert scale with responses ranging from "Strongly Disagree" to "Strongly Agree".
Scores on each item will be reported with means and standard deviations.
|
Assessed once after completion of the study at 10 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 5, 2021
Primary Completion (Actual)
May 4, 2022
Study Completion (Actual)
May 31, 2022
Study Registration Dates
First Submitted
July 2, 2021
First Submitted That Met QC Criteria
July 12, 2021
First Posted (Actual)
July 19, 2021
Study Record Updates
Last Update Posted (Actual)
June 13, 2022
Last Update Submitted That Met QC Criteria
June 9, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 20-1166
- 1P30AG063786-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
All collected individual participant data (IPD) will be de-identified and pooled before sharing on the Open Science Framework, along with a data dictionary.
Pooling personalized trials together is a more efficient approach for deriving population-level estimates than conventional randomized controlled trials.
IPD Sharing Time Frame
The study protocol, including the statistical analysis plan, will be made available in addition to the informed consent form following completion of recruitment but prior to publication of any data from the current study.
De-identified, pooled individual participant data will be made available within a year of final participant data collection.
We anticipate this data to be available on the Open Science Framework platform indefinitely.
IPD Sharing Access Criteria
All data and supporting information will be stored on the Open Science Framework, a free web application with no access restrictions.
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sedentary Behavior
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSedentary Behavior | Sedentary TimeUnited States
-
Stanford UniversityActive, not recruiting
-
University of California, San DiegoCompleted
-
Cairo UniversityRecruitingSedentary BehaviorsEgypt
-
Istanbul Aydın UniversityCompletedSedentary Lifestyle | Functional CapacityTurkey (Türkiye)
-
Gazi UniversityCompletedSedentary | Athlete | Core Muscle EnduranceTurkey (Türkiye)
-
China-Japan Friendship HospitalNot yet recruitingSedentary Lifestyle | Behavioral Intervention
-
Sezer TaştanCompletedSedentary Lifestyle | Cardiorespiratory FitnessTurkey (Türkiye)
-
Recep Tayyip Erdogan UniversityCompletedPhysical Inactivity | Sedentary BehaviorsTurkey (Türkiye)
-
Research on Healthcare Performance Lab U1290RecruitingSedentary Behavior | Sedentary Time | Health Behavior | Health-Related Behavior | Physical InactivityFrance
Clinical Trials on Behavioral Change Techniques
-
Northwell HealthNational Institute on Aging (NIA)CompletedInsufficient Physical ActivityUnited States
-
Northwell HealthNational Institute on Aging (NIA)CompletedMedication AdherenceUnited States
-
Northwell HealthToronto Dominion BankCompletedMedication AdherenceUnited States
-
Ludwig-Maximilians - University of MunichChild Health Foundation; Johnson & Johnson Citizenship Trust, in cooperation... and other collaboratorsCompleted
-
Adhera Health, Inc.Hospital Miguel Servet; Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...CompletedEmotional Adjustment | Mood DisturbanceSpain
-
Research Foundation for Mental Hygiene, Inc.Columbia UniversityCompletedStigma, Social | Help-Seeking BehaviorUnited States
-
Research Institute of Child Nutrition, DortmundCompleted
-
University of LisbonFundação para a Ciência e a Tecnologia; Faculdade de Psicologia, Universidade... and other collaboratorsCompletedParental Feeding Practices and Children's Healthy DietPortugal
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedBreast Cancer | Endometrial Cancer | Diabetes Mellitus, Non-Insulin-Dependent
-
Boston Medical CenterCenters for Disease Control and PreventionCompleted